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Abstract
Background: Several studies have reported high prevalence of anxiety and depression in chronic obstructive
pulmonary disease (COPD) outpatients. Moreover, these patients share psychological or psychopathological
characteristics that inhibit their ability to cope with the disease. In the present study we aimed to record the
prevalence of psychological symptom patterns in a sample of Greek COPD outpatients and to assess which
psychological factors (and to which degree) contribute to vital exhaustion (VE).
Methods: The study included 139 COPD outpatients. We used the Symptom Checklist 90 - Revised (SCL-90-R) and
the Maastricht Questionnaire (MQ) in order to evaluate psychological symptom patterns and VE, respectively.
Results: The mean MQ score was 19.6, which is significantly higher than the corresponding score in the general
population. Regarding the SCL-90-R dimensions, depression was the highest followed by somatization, obsessive-
compulsive and anxiety dimensions. Additionally, a positive correlation was observed between the MQ and the SCL-90-
R dimensions. MQ failed to demonstrate correlation with age, gender, education level or the severity of the disease.
Depression seems to be responsible for 57.9% of the variation of VE, while obsessive-compulsiveness is responsible for
an additional 2.4%. All the remaining dimensions of SCL-90-R had no statistically significant contributions.
Conclusions: Our findings suggest the high prevalence of VE, together with high rates in most of the SCL-90-R
dimensions with greater depression, somatization, obsessive-compulsiveness and anxiety in a Greek COPD group at
various Global Initiative for Chronic Obstructive Lung Disease (GOLD) diagnostic criteria stages. The coexistence of
such symptoms should be further assessed as an eventual unfavorable prognostic factor.
Background
Chronic obstructive pulmonary disease (COPD) is char-
acterized by chronic airflow limitation and a range of
pathological changes in the lung, some significant extra-
pulmonary effects and important comorbidities that may
contribute to the severity of the disease in individual
patients [1]. The most common symptoms, but not spe-
cific for COPD, are breathlessness (’need for air’), exces-
sive sputum production and chronic persistent cough
[2].
Although there are several studies that have suggested
that the prevalence of anxiety and depression is higher
in patients with COPD than in patients with other
chronic diseases, it is possible that there are certain psy-
chological or psychopathological factors in these
patients that influence their ability to cope with the dis-
ease [3].
Vital exhaustion (VE) is defined as a state character-
ized by unusual fatigue and lack of energy, increasing
irritability and feelings of demoralization, typically
attributed to prolonged psychological stress [4,5]. The
concept of VE grew out of an interest in understanding
the nature of the feeling of unusual tiredness that is
reported among patients with cardiovascular diseases
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found significantly high levels of vital exhaustion in
patients with bronchial asthma [7].
It is known that mortality in COPD is more often due
to cardiac rather than respiratory causes [8,9]. However,
psychological comorbidities, and especially depressive
symptoms, are independent prognostic factors for mor-
tality among stable COPD patients [10].
Taking into account the limited information in the lit-
erature, especially in Greece, regarding the prevalence of
overall psychological comorbidities and of VE in COPD
outpatients, we aimed to record their prevalence and
their associations in a sample of Greek COPD outpati-
ents and to assess which psychological factors (and to
which degree) contribute to VE.
Methods
Sample
We selected 139 COPD outpatients to participate in the
study from the outpatients list of scheduled appoint-
ments in our hospital’s clinics (among the largest
respiratory diseases hospitals in Europe) by using an
Excel random algorithm. No patient refused to partici-
pate in the study; the participants were approached at a
referral center and were very motivated. We excluded
patients who were aged > 80 years and patients diag-
nosed with major comorbidities such as heart failure,
myocardial infarction, cerebrovascular disease, cancer, or
severe orthopedic disorders as well as major mental dis-
orders such as schizophrenia or mood disorder. Related
information was obtained from the subjects’ medical his-
tories and medical records. Age, gender, family status
and years of education were noted.
Physiological measures
In order to determine COPD severity of our sample, a
spirometric evaluation after 4 weeks without an acute
exacerbation, before and after bronchodilation (200 μg
salbutamol), was performed. We followed the Global
Initiative for Chronic Obstructive Lung Disease (GOLD)
diagnostic criteria, which classifies COPD severity (in
relation to forced expiratory volume in 1 second (FEV1)/
forced vital capacity (FVC) ratio (FEV1%) predicted) into
four stages: stage I (mild COPD) = FEV1 > 80% pre-
dicted; stage II (moderate COPD) = FEV1 50% to 80%
predicted; stage III (severe COPD) = FEV1 30% to 50%
predicted; and stage IV (very severe COPD) = FEV1 <
30% predicted [1].
Psychological measures
Symptom Checklist 90 - Revised (SCL-90-R)
The SCL-90-R is a 90-item self-report symptom inven-
tory designed to reflect psychological symptom patterns
of psychiatric and medical patients. Each item of the
questionnaire is rated on a 5-point scale of distress from
0 (none) to 4 (extreme). The SCL-90-R consists of the
following nine primary symptom dimensions: somatiza-
tion (SOM, which reflects distress arising from bodily
perceptions), obsessive-compulsive (OC, which reflects
obsessive-compulsive symptoms), interpersonal sensitiv-
ity (IS, which reflects feelings of personal inadequacy
and inferiority in comparison with others), depression
(DEP, which reflects depressive symptoms, as well as
lack of motivation), anxiety (ANX, which reflects anxiety
symptoms and tension), hostility (HOS, which reflects
symptoms of negative affect, aggression and irritability),
phobic anxiety (PHO, which reflects symptoms of per-
sistent fears as responses to specific conditions), para-
noid ideation (PAR, which reflects symptoms of
projective thinking, hostility, suspiciousness, fear of loss
of autonomy), and psychoticism (PSY, which reflects a
broad of symptoms from mild interpersonal alienation
to dramatic evidence of psychosis) [11,12].
The SCL-90 takes between 12 and 20 min to com-
plete. With regard to its reliability, the internal consis-
tency coefficient a values for the nine symptom
dimensions ranged from 0.77 for psychoticism, to a high
of 0.90 for depression. Additionally, the few validity stu-
dies of the SCL-90-R demonstrate levels of concurrent,
convergent, discriminant, and construct validity compar-
able to other self-report inventories. The SCL-90-R has
been standardized and used in the Greek population
and its reliability (Cronbach’s a) for the total of the
items is 0.97 [13,14]. The cutoff for the SCL-90-R sub-
scales is 0.99 [14].
Maastricht Questionnaire (MQ)
The MQ is a self-report questionnaire consisting of 21
items that describe different aspects of VE, such as fati-
gue (for example, item 1: ‘Do you often feel tired?’), lack
of energy (for example, item 15: ‘Do you sometimes feel
that your body is like a battery that is losing its
power?’), irritability (for example, item 12: ‘Do little
things irritate you more lately than they used to?’),
demoralization (for example, item 13: ‘Do you feel you
want to give up trying?’), and depressive mood (for
example, item 19: ‘Do you feel like crying sometimes?’)
with a possible score range from 0 to 42 and good inter-
nal consistency (Cronbach’s a,0 . 8 9 ) .T h em e a nM Q
score in a healthy population is 8.8 (± 8.7), with a cutoff
> 18 [15,16]. The questionnaire has been adapted into
the Greek language and its reliability is considered to be
satisfactory (Cronbach’s a, 0.87) [16].
Regarding sample size calculation, for 16 independent
variables, and assuming an a level of 0.05, a medium
anticipated effect size (f2) of 0.15 and a desired statisti-
cal power level of 0.8, Cohen’s formula [17] gives a
required sample size of 142. Our sample size (see next
section) just falls short of this level, but is amply
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method of Green [18], which, for 16 independent vari-
ables, gives a sample size of 119.
Statistical analyses were performed using the Student’s
t test, Pearson’s correlation and stepwise (backward
eliminating) multiple linear regression (that is, removing
one parameter at a time with the highest P value). Sta-
tistical significance was set at P < 0.05.
The hospital ethics committee approved the study and
all participants provided their consent. No financial sup-
port was necessary.
Results
In all, 139 COPD outpatients were included in the
study: 107 men (mean age = 64.92, SD = 8.16) and 32
women (mean age = 63.66, SD = 7.74), with mean dura-
tion (in years) of education 10.9 (SD = 4.07). The mean
FEV1 was 43.5 ± 14.6% predicted (Table 1). There was
no statistical difference between males and females,
regarding age, level of education, and FEV1% predicted
(t test P > 0.05).
With regard to gender, females presented with higher
mean scores in depression, obsessive-compulsiveness,
anxiety, hostility and somatization than males (t test P <
0.05, Table 2). The mean MQ score was 19.6 (Table 2),
which is significant higher than the corresponding to
the general population (8.7) adjusted for age and sex
[16] (sample t test P < 0.05). However, gender was not
associated with vital exhaustion (t test P > 0.05).
Regarding the SCL-90-R dimensions, depression pre-
sented the higher mean score, followed by somatization,
obsessive-compulsive and anxiety dimensions (Table 2).
One out of two patients presented a clinically signifi-
cant elevation (score > 0.99) in at least one dimension
of the SCL-90-R. A total of 36% of the participants pre-
sented with depression, while 33% presented somatiza-
tion, 30.9% obsessive-compulsiveness and 23.7% anxiety
(Table 3).
We observed a positive correlation between depression
and all the other dimensions of SCL-90-R (Pearson cor-
relation P < 0.01), while the stronger correlation was
observed with obsessive-compulsiveness (Pearson corre-
lation r = 0.700, P < 0.01) and anxiety (Pearson correla-
tion r = 0.700, P < 0.01). No correlation was found
between SCL-90-R dimensions and age or education
level.
Additionally, a positive correlation was observed
between MQ and SCL-90-R dimensions (Pearson corre-
lation P < 0.01, Table 4). MQ failed to demonstrate cor-
relation with age, education level or FEV1% of predicted
(Pearson correlation P > 0.05).
Finally, FEV1% of predicted presented a weak correla-
tion only with somatization (Pearson correlation: r =
0.267, P < 0.05), while there was no correlation with
MQ (Pearson correlation: r = 0.02, P > 0.05).
In order to examine the factors that participate to the
elevation of MQ score we used stepwise multiple regres-
sion. We included all nine symptom dimensions of the
SCL-90-R: depression seems to be responsible for 57.9%
of the variation of vital exhaustion (F1,137 = 186.77, P <
0.001), while obsessive-compulsiveness is responsible for
an additional 2.4% (F1,136 = 8.14, P < 0.001). All the
remaining dimensions of SCL-90-R had no statistically
significant contributions.
Discussion
The main findings of our research suggest the high pre-
valence of VE together with high rates in most of the
SCL-90-R dimensions with greater depression, somatiza-
tion, obsessive-compulsiveness and anxiety. In a pre-
vious study using the SCL-90-R, the authors found
similar rates in somatization, depression, anxiety and
hostility [3]. These observations, in agreement with
other findings in the literature, underline the association
of psychological status of Greek COPD patients with
their ability to cope with the disease and subsequently
with their quality of their life [19,20].
It is known that psychological characteristics interact
with physical symptoms and play an important role in
how COPD patients experience and manage their dis-
ease [21]. According to this finding, the investigation of
the prevalence of the psychological symptoms of these
patients is established as necessary.
However, the relevant psychological status studies
have mainly been focused on the prevalence of anxiety
and depression, which often appear together in these
patients [22-26]. The prevalence of depression among
outpatients with COPD is substantially greater than
Table 1 Demographics and baseline characteristics
Male (N = 107) Female (N = 32) Total (N = 139) t Test (df = 137)
Mean SD Mean Mean SD
Age 64.91 8.15 63.65 7.74 64.62 8.05 P > 0.05
Education (years) 10.59 4.05 11.9 4.027 10.89 4.07 P > 0.05
FEV1% of predicted 41.45 20.23 52.17 23.26 43.48 21.15 P = 0.05
Severity as per Global Initiative for Chronic Obstructive Lung Disease (GOLD) diagnostic criteria: mild/moderate/severe/very severe 10/19/47/35.
FEV1% = forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio.
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10% and 42% in the former, compared to approximately
5% in the latter). Correspondingly, the prevalence of
anxiety varies from 10% to 19% [26], a percentage that
is higher than the 15% reported in the general popula-
tion [27,28]. Higher predominance of depression and
anxiety was observed in patients with COPD compared
to patients that suffered from other chronic respiratory
disorders, such as bronchial asthma and tuberculosis
[28]. Both depression and anxiety are significantly asso-
ciated with decreased functional status and worse health
status when compared to those of patients without psy-
chological symptoms, even after controlling for the
effects of overall health status [24,29,30]. In a previous
study we showed the high prevalence of anxiety and
depressive symptoms, together with their association
with alexithymia (’lack of words for emotions’)i nG r e e k
COPD outpatients [31].
In another relevant previous study [32], which used
the SCL-90-R for the evaluation of psychological symp-
toms in COPD patients, the authors concluded that
somatization, anxiety and depression correlated with
behavioral impairment of multiple daily activities.
Regarding VE, there are no studies in the literature for
COPD patients. However, in a study concerning fatigue
(which is the main symptom of VE) it was shown that
almost all participants with COPD experienced this
symptom. Furthermore, fatigue affected greater propor-
tions of participants than either anxiety or depression
[33], a finding similar to our results.
However, depression and vital exhaustion have impor-
tant symptoms in common, most notably increased fati-
gue and irritability, which raises the question as to what
extent these constructs may differ from each other [34].
Two previous studies that were designed to investigate
this question concluded that VE is characterized by loss
of vigor and fatigue rather than depressed mood [35].
Furthermore, VE is related more to loss of energy and
bodily symptoms, whereas depression is more related to
dysfunction attitudes, lack of purpose, low self-efficacy
and hostility [36].
In a previous study in patients following first myocar-
dial infarction, depression and fatigue were highly corre-
lated and their association was not attributable to
comorbid physical illnesses or the tendency of the MQ
to measure depression [37]. However, according to the
findings of the present study, depressive symptoms have
an effect on the degree of VE, leading to a more com-
plex clinical aspect; their prognostic value needs to be
assessed with further studies.
COPD contributes to an impaired quality of life [38].
Fatigue, which is the main feature of VE, imposes lim-
itations on motivation, concentration and the ability to
engage in everyday activities, engendering frustration
Table 2 Mean, SD, median for Symptom Checklist 90 Revised (SCL-90-R) and the Maastricht Questionnaire (MQ) with
regard to gender
Male (N = 107) Female (N = 32) Total (N = 139) t Test (df = 137)
Mean SD Median SD Median Mean SD Median
SOM 0.72 0.46 0.58 1.04 0.69 0.83 0.80 0.54 0.66 P < 0.01
OC 0.68 0.50 0.50 1.08 0.66 0.90 0.77 0.56 0.70 P < 0.001
IS 0.41 0.47 0.22 0.63 0.56 0.49 0.46 0.50 0.33 P > 0.05
DEP 0.80 0.60 0.61 1.19 0.64 1.07 0.89 0.63 0.69 P < 0.01
ANX 0.60 0.53 0.50 0.91 0.71 0.70 0.67 0.59 0.50 P < 0.01
HOS 0.47 0.63 0.33 0.80 0.74 0.66 0.54 0.67 0.33 P < 0.05
PHO 0.36 0.58 0.14 0.45 0.72 0.28 0.38 0.61 0.14 P > 0.05
PAR 0.43 0.55 0.33 0.56 0.68 0.33 0.46 0.58 0.33 P > 0.05
PSY 0.15 0.34 0.00 0.30 0.44 0.20 0.18 0.37 0.00 P > 0.05
MQ 18.96 8.56 18.00 21.84 9.54 21.00 19.62 8.84 19.00 P > 0.05
ANX = anxiety; DEP = depression; IS = interpersonal sensitivity; HOS = hostility; OC = obsessive-compulsive; PAR = paranoid ideation; PHO = phobic anxiety; PSY
= psychotism; SOM = somatization.
Table 3 Patients (N, %) with clinically significant
symptoms on the Symptom Checklist 90 Revised (SCL-90-
R) and the Maastricht Questionnaire (MQ)
Scale Factor N %
SCL-90-R Without psychopathology > 0.99 62 44.6
Somatization (SOM) > 0.99 47 33.8
Obsessive-compulsive (OC) > 0.99 43 30.9
Interpersonal sensitivity (IS) > 0.99 19 13.7
Depression (DEP) > 0.99 50 36.0
Anxiety (ANX) > 0.99 33 23.7
Hostility (HOS) > 0.99 28 20.1
Phobic anxiety (PHO) > 0.99 18 12.9
Paranoid ideation (PAR) > 0.99 23 16.5
Psychoticism (PSY) > 0.99 7 5.0
MQ Vital exhaustion > 18 71 51.1
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ity, as determined by FEV1% of predicted, failed to
demonstrate correlation with VE and SCL-90-R dimen-
sions, with the exception of somatization (which may
reflect the underlying symptoms of the disease). This
observation is in line with the hypothesis that FEV1% of
predicted does not mediate all the aspects of the disease
and demonstrates poor correlation with quality of life
[39]. It is possible that the patients construe disease ser-
iousness with a subjective view, which contributes to the
development of the levels of psychological distress [31].
This study has limitations: the most important relates
to the fact that the design did not include verification of
the hypothesis that the simultaneous presence of a high
degree of psychological comorbidity and VE is possibly
a predictor of adverse outcomes in COPD. This hypoth-
esis should be tested with different types of further
studies.
Conclusions
Our findings suggest the high prevalence of VE together
with high rates in most of the SCL-90-R dimensions
with greater depression, somatization, obsessive-compul-
siveness and anxiety in a Greek COPD group at various
GOLD stages. The coexistence of such symptoms
should be further assessed as an eventual unfavorable
prognostic factor.
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